Table 1. Baseline characteristics of the patients.
| No. | Age (y) | Sex | BMI c (kg/m2) | Smoking | Hypertension | Diabetes | Aneurysm location | Aneurysm diameter (mm) | Aneurysm form | Thrombus thickness (mm) | Intraluminal thrombus volume (%) | PPI d/H2 blockere | Statin | Intestinal drug |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 65 | Ma | 24.5 | (+) | (+) | (-) | Infrarenal | 47 | Fusiform | 13 | 37 | (-) | (-) | (-) |
| 2 | 62 | M | 17.1 | (+) | (-) | (-) | Infrarenal | 53 | Fusiform | 10 | 47 | (-) | (+) | (-) |
| 3 | 71 | M | 23.5 | (+) | (-) | (-) | Infrarenal | 45 | Fusiform | 25 | 26 | (-) | (-) | (-) |
| 4 | 64 | M | 33.1 | (+) | (+) | (+) | Infrarenal | 48 | Fusiform | 7 | 24 | (-) | (+) | (-) |
| 5 | 68 | M | 25.9 | (+) | (-) | (+) | Infrarenal | 53 | Saccular | 18 | 73 | (-) | (+) | (-) |
| 6 | 74 | M | 22.7 | (+) | (-) | (-) | Infrarenal | 52 | Fusiform | 2 | 15 | (-) | (+) | (-) |
| 7 | 72 | M | 25.9 | (+) | (+) | (+) | Infrarenal | 43 | Fusiform | 25 | 80 | (+) | (+) | (-) |
| 8 | 76 | M | 21.7 | (+) | (-) | (-) | Infrarenal | 58 | Fusiform | 22 | 75 | (-) | (-) | (-) |
| 9 | 75 | M | 21.3 | (+) | (+) | (-) | Infrarenal | 50 | Fusiform | 11 | 82 | (+) | (-) | (-) |
| 10 | 48 | M | 37.3 | (+) | (+) | (-) | Common iliac | 38 | Fusiform | 12 | 64 | (-) | (+) | (+) |
| 11 | 74 | M | 25.8 | (+) | (+) | (-) | Infrarenal | 51 | Fusiform | 26 | 77 | (-) | (+) | (-) |
| 12 | 63 | M | 23.1 | (+) | (+) | (+) | Infrarenal | 48 | Fusiform | 2 | 14 | (-) | (+) | (-) |
| 13 | 76 | M | 21.1 | (+) | (-) | (+) | Infrarenal | 53 | Fusiform | 20 | 76 | (+) | (-) | (+) |
| 14 | 64 | M | 16.0 | (+) | (+) | (+) | Infrarenal | 85 | Fusiform | - | - | (+) | (-) | (-) |
| 15 | 60 | M | 27.8 | (+) | (-) | (-) | Infrarenal | 43 | Fusiform | 0 | 0 | (-) | (-) | (-) |
| 16 | 70 | M | 25.3 | (+) | (+) | (-) | Infrarenal | 53 | Fusiform | 4 | 8 | (-) | (+) | (-) |
| 17 | 56 | M | 29.8 | (+) | (+) | (-) | Infrarenal | 80 | Fusiform | 28 | 55 | (-) | (-) | (-) |
| 18 | 69 | Fb | 24.8 | (+) | (+) | (-) | Infrarenal | 35 | Sacciform | 5 | 24 | (-) | (-) | (-) |
| 19 | 77 | F | 24.4 | (+) | (+) | (-) | Infrarenal | 51 | Fusiform | 0 | 0 | (-) | (+) | (-) |
| 20 | 73 | M | 24.5 | (+) | (-) | (-) | Infrarenal | 49 | Fusiform | 4 | 20 | (-) | (-) | (-) |
| 21 | 64 | M | 21.5 | (+) | (+) | (-) | Infrarenal | 67 | Fusiform | 15 | 57 | (-) | (+) | (-) |
| 22 | 68 | M | 24.5 | (+) | (+) | (-) | Infrarenal | 53 | Fusiform | 23 | 60 | (-) | (+) | (-) |
| 23 | 73 | M | 25.5 | (-) | (+) | (-) | Infrarenal | 53 | Fusiform | 7 | 14 | (-) | (-) | (-) |
| 24 | 62 | M | 17 | (+) | (-) | (-) | Infrarenal | 60 | Fusiform | 15 | 35 | (-) | (-) | (-) |
| 25 | 66 | M | 23.4 | (+) | (+) | (-) | Infrarenal | 50 | Fusiform | 9 | 23 | (+) | (+) | (-) |
| 26 | 67 | M | 23.9 | (+) | (-) | (-) | Infrarenal | 50 | Fusiform | 26 | 71 | (-) | (+) | (+) |
| 27 | 77 | M | 25.2 | (+) | (-) | (-) | Infrarenal | 45 | Fusiform | 10 | 30 | (+) | (+) | (-) |
| 28 | 68 | M | 27.8 | (+) | (+) | (+) | Infrarenal | 54 | Fusiform | 25 | 73 | (+) | (+) | (-) |
| 29 | 68 | M | 24.8 | (+) | (+) | (-) | Infrarenal | 47 | Fusiform | 7 | 27 | (+) | (+) | (-) |
| 30 | 65 | M | 22.5 | (+) | (+) | (-) | Infrarenal | 50 | Fusiform | 15 | 49 | (+) | (+) | (-) |
aM; male.
bF; female.
cBMI; body mass index.
dPPI; proton pomp inhibitor.
eH2 blocker; histamine H2-receptor antagonist.